内源性GDNF升高致小鼠多巴胺信号改变并与精神分裂症临床严重度相关
该研究在小鼠中条件性增加内源性GDNF表达,发现2-3倍升高足以诱导纹状体和前额叶皮质多巴胺信号的分子、细胞和功能改变,包括纹状体突触前多巴胺水平升高和前额叶皮质多巴胺减少。A2AR可能介导GDNF驱动的多巴胺异常,药理学抑制A2AR可部分正常化小鼠纹状体GDNF及纹状体和皮质多巴胺水平。首次发作精神病患者脑脊液和精神分裂症患者尸检纹状体中GDNF水平升高。
要点
- 内源性GDNF升高2-3倍可致小鼠纹状体突触前多巴胺升高、前额叶皮质多巴胺减少。
- A2AR可能介导GDNF驱动的多巴胺异常,抑制A2AR可部分正常化小鼠多巴胺水平。
- 首次发作精神病患者脑脊液及精神分裂症患者尸检纹状体中GDNF水平升高。
核心结论
- 内源性GDNF升高可能贡献于部分精神分裂症患者的纹状体多巴胺信号增强,GDNF-A2AR交互作用可能以可治疗靶向的方式调节多巴胺功能。
研究设计与样本
- 研究开发了一种新型体内方法条件性增加内源性GDNF表达,以避免异位过表达引起的不良效应,并在小鼠中测试GDNF升高的影响。
- 研究检测了GDNF升高对小鼠纹状体和前额叶皮质多巴胺信号的影响,并探究A2AR作为潜在介导者。
- 研究进一步检测了首次发作精神病患者脑脊液和精神分裂症患者尸检纹状体中的GDNF水平。
主要发现
- 小鼠脑内内源性GDNF升高2-3倍足以诱导纹状体和前额叶皮质多巴胺信号的分子、细胞和功能改变,包括纹状体突触前多巴胺水平升高和前额叶皮质多巴胺减少。
- 腺苷A2a受体(A2AR)被鉴定为GDNF驱动的多巴胺异常的可能介导者。
- 使用istradefylline药理学抑制A2AR可部分正常化小鼠纹状体GDNF以及纹状体和皮质多巴胺水平。
- 首次发作精神病患者脑脊液中GDNF水平升高,精神分裂症患者尸检纹状体中GDNF水平升高。
关键数值与推荐
- 小鼠脑内内源性GDNF升高2-3倍足以诱导多巴胺信号改变。
- istradefylline药理学抑制A2AR可部分正常化小鼠纹状体GDNF和纹状体及皮质多巴胺水平。
- 首次发作精神病患者脑脊液中GDNF水平升高。
- 精神分裂症患者尸检纹状体中GDNF水平升高。
临床怎么用
- GDNF-A2AR交互作用可能作为调节多巴胺功能的治疗靶点,但需进一步临床研究验证。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Presynaptic increase in striatal dopamine is the primary dopaminergic abnormality in schizophrenia, but the underlying mechanisms are not understood. Here, we hypothesized that increased expression of endogenous GDNF could induce dopaminergic abnormalities that resemble those seen in schizophrenia. To test the impact of GDNF elevation, without inducing adverse effects caused by ectopic overexpression, we developed a novel in vivo approach to conditionally increase endogenous GDNF expression. We found that a 2-3-fold increase in endogenous GDNF in the brain was sufficient to induce molecular, cellular, and functional changes in dopamine signalling in the striatum and prefrontal cortex, including increased striatal presynaptic dopamine levels and reduction of dopamine in prefrontal cortex. Mechanistically, we identified adenosine A2a receptor (A2AR), a G-protein coupled receptor that modulates dopaminergic signalling, as a possible mediator of GDNF-driven dopaminergic abnormalities. We further showed that pharmacological inhibition of A2AR with istradefylline partially normalised striatal GDNF and striatal and cortical dopamine levels in mice. Lastly, we found that GDNF levels are increased in the cerebrospinal fluid of first episode psychosis patients, and in post-mortem striatum of schizophrenia patients. Our results reveal a possible contributor for increased striatal dopamine signalling in a subgroup of schizophrenia patients and suggest that GDNF-A2AR crosstalk may regulate dopamine function in a therapeutically targetable manner.
引用
- Mätlik K, Garton DR, Montaño-Rodríguez AR, et al. Elevated endogenous GDNF induces altered dopamine signalling in mice and correlates with clinical severity in schizophrenia. Mol Psychiatry. 2022. PMID: 35618883. doi:10.1038/s41380-022-01554-2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。